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ABSTRACT 
A rapid, reliable, sensitive UV-spectrophotometric method has been developed for the determination of Balofloxacin in bulk and marketed tablet dosage form 
using 1 % w/v of ferrous sulphate as a chromagenic / complexing agent. The yellow colour complex formed by complexation of iron (II) with balofloxacinwas 
stable and was measured for absorbance at its λ max of 357 nm. The Beers law was obeyed at the concentration range of 10-100 µg / ml with good correlation 
coefficient of 0.9992. The method was optimized and validated for linearity, accuracy and precision. The proposed method is simple and can be routinely used 
for the estimation of balofloxacin in its tablet formulations. 
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INTRODUCTION 
Balofloxacin(BLFX),1-cyclopropyl-6-fluoro-8methoxy-7-(3-
methylaminopiperidin-1-yl)-4-oxoquinoline-3-carboxylic 
acid
1, is a broad spectrum fourth generation fluoroquinolone 
antibacterial,  having  a  formula  as  C20H24FN3O4  and 
molecular  mass  389.42  g  /  mol.  It  exhibits  excellent 
antibacterial activity against gram-positive bacteria such as 
multiple-drug-resistant  staphylococci  and  pneumococci.  It 
acts  by  binding  to  and  inhibiting  topoisomerase  II  (DNA-
gyrase)  and  topoisomerase  IV  enzymes,  which  are 
responsible for the coiling and uncoiling of DNA, which is 
needed  for  bacterial  cell  repair  and  replication
2.  Several 
analytical methods such as UV spectrophotometric method
1,3, 
HPLC  determination  in  biological  fluids
4,  HPLC 
determination in human plasma with solid extraction
5, RP-
HPLC
6,  RP-HPLC  with  fluorescence  detection
7,  HPLC-
Electropray  ionization  mass  spectroscopy
8,  have  been 
developed for determination of Balofloxacin. In the current 
study a simple, rapid and reliable visible spectrophotometric 
method was developed and validated for linearity, accuracy, 
precision  and  specificity.  The  method  was  extended  for 
determination  of  balofloxacin  in  the  marketed  tablet 
formulation (Baloforce
TM Tablet manufactured by Mankind, 
New Delhi, India). 
 
 
Balofloxacin 
 
Method 
Perkin  Elmer  Lambda  25  uv  /  vis  spectrophotometer  was 
used  for  recording  the  absorbance.  Reference  standard  of 
Balofloxacin  was  kindly  received  from  Cirex 
Pharmaceuticals (P) Ltd, Hyderabad, India. All the solvents 
used were of analytical grade. 
 
Preparation of standard drug solution 
A  1  mg  /  ml  of  stock  solution  was  prepared  in  a  10  ml 
volumetric flask by dissolving 10 mg of balofloxacin in 0.1N 
hydrochloric acid, diluting to the mark with the same acid. 
 
Preparation of 1 % w/v of ferrous sulphate (Reagent) 
A  1  %  w/v  of  ferrous  sulphate  reagent  was  prepared  by 
weighing 100 mg of the solid ferrous sulphate and acidifying 
in 1 ml of 0.1N hydrochloric acid in 10 ml volumetric flask 
and diluting up to the mark with water. 
 
Standard Calibration Plot 
Aliquots of the stock solution ranging from 0.1 ml to 1 ml 
were taken in separate 10 ml volumetric flasks and 3.5 ml 
each of reagent was added, further diluted to the mark with 
water to get the working standard solution of concentrations 
10  –  100  μg  /  ml.  The  absorbance  of  each  solutions  was 
measured  at  357  nm  against  reagent  blank  (Figure  1).  A 
standard  calibration  curve  was  prepared  by  plotting 
absorbance versus concentration of balofloxacin (Figure 2). 
Further, with optimized conditions, the proposed method was 
validated  for  linearity,  accuracy,  precision,  sensitivity, 
reproducibility and stability of colour. Recovery studies were 
carried  out  by  mixing  standard  solutions  of  the  drug  at  3 
different levels (75 %, 100 % and 125 %) with previously 
analyzed tablet samples of  balofloxacin. The results of the 
validation study and recovery study is presented in Table 1 
and Table 2 respectively. 
 
Estimation of Balofloxacin from tablets 
10  tablets  of  (Baloforce)  containing  100  mg  of  the  active 
ingredient in each tablet was weighed and powdered. Tablet 
powder, equivalent to 25 mg of balofloxacin was transferred 
to 25 ml of volumetric flask and sonicated using 5 ml of 0.1N 
hydrochloric acid at ambient temperature for 15 minutes. The 
resulting solution was filtered using whatman filter paper no. 
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hydrochloric acid. Different aliquot volumes of this solution 
was taken in 10 ml volumetric flasks to which 3.5 ml of 1 % 
w/v of ferrous sulphate was added and diluted to mark with 
water. The absorbance of the sample solutions was recorded 
against  reagent  blank  prepared  in  a  similar  manner,  but 
excluding  the  sample.  The  amount  of  balofloxacin  was 
calculated from the calibration curve (Figure 2). 
 
 
 
 
Figure 1: Absorbance Maxima Spectra 
 
 
 
Figure 2: Standard Calibration Plot 
 
Table 1: Validation Parameters 
 
Parameters  Observations 
Linearity  10 – 100 µg / ml 
Precision  0.039 % RSD 
Sandell’s sensitivity  3.512 x 10
-2 µg / cm
2 
Equation of linearity graph 
Slope: 
Intercept: 
0.023x + 0.072 
0.023 
0.072 
Stability of Colour  2 h 
 
Table 2: Results of Recovery Study 
 
Standard concentration 
(in µg / ml) 
Sample concentration 
(µg / ml) 
Absorbance at 357 
nm 
Total concentration as calculated from 
linearity graph 
% Std Recovery 
7.5  10  0.4781  17.33  99.02 % 
10.0  10  0.5483  20.33  101.65 % 
12.5  10  0.6025  22.66  100.70 % 
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RESULTS AND DISCUSSION 
Balofloxacin,  forms  a  yellow  coloured  solution  after 
complexing with the iron (II) in 1 % w/v ferrous sulphate. 
The  developed  method  was  linear  over  the  concentration 
range of 10 – 100 μg / ml. Accuracy was determined from 
recovery study at 3 different levels of 75 %, 100 % and 125 
%, by adding standard solution of balofloxacin to previously 
analysed tablet samples of balofloxacin. Average recovery of 
99.02  %  to  101.65  %  indicated  accuracy  of  the  method. 
Sandell’s sensitivity was determined and found to be 3.512 X 
10
-2 µg / cm
2. The colour was found to be stable. The results 
of assay showed that the amount of drug determined by new 
method  was  in  good  agreement  with  the  label  claim  of 
formulation. From the above results it can be concluded that 
the developed visible spectrophotometric method is simple, 
rapid, accurate, precise and economical. Hence the method 
can  be  applied  for  quantitative  analysis  of  balofloxacin  in 
bulk and pharmaceutical formulation like tablet dosage form. 
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